UK Medicines Information
Medicines related to valproate: risk of abnormal pregnancy outcomes
Information type:
Safety alerts
Source:
Central Alerting System
Specialities:
Neurological disorders | Obstetrics and gynaecology | Paediatric and neonatal medicine
Summary
Following a Europe-wide review, the MHRA is advising that valproate should not be prescribed to female children, female adolescents, women of childbearing potential or pregnant women unless other treatments are ineffective or not tolerated.
UKMi comment
Valproate is now a black triangle medicine and is subject to additional monitoring.
Related links: